Page 204 - Medicine and Surgery
P. 204

P1: KPE
         BLUK007-05  BLUK007-Kendall  May 25, 2005  8:52  Char Count= 0








                   200 Chapter 5: Hepatic, biliary and pancreatic systems


                   Table 5.5 Hepatotrophic viruses
                   Virus                      Type                  Transmission         Incubation period
                   Hepatitis A virus (HAV)    ssRNA                 faecal/oral          ∼1month
                   Hepatitis E virus (HEV)    ssRNA                 faecal/oral          ∼1–2 months
                   Hepatitis B virus (HBV)    dsDNA                 blood/sexual         ∼2–3 months
                   Hepatitis D virus (HDV)    Defective RNA         blood/sexual         Needs HBV for replication
                   Hepatitis C virus (HCV)    ssRNA                 blood/sexual         ∼2–3 months



                     β-blockers may be used as secondary prophylaxis ei-  Geography

                     ther in combination with endoscopic therapies or  Endemic in developing countries, with exposure in early
                     alone. If they are used alone, it is recommended that  childhood being common and adults universally im-
                     hepatic venous pressure gradient is measured to con-  mune. In developed countries, most cases are sporadic
                     firm the success of treatment.              and the numbers are declining.
                     TIPSS is more effective than endoscopic treatment in

                                                                Aetiology/pathophysiology
                     reducingvaricealrebleedingbutdoesnotimprovesur-
                                                                ssRNA enterovirus of the picorna group. HAV is trans-
                     vival and is associated with more encephalopathy.
                                                                mitted by the faecal–oral route (especially in seafood)
                                                                and has an incubation period of 2–6 weeks. It is infec-
                   Prognosis                                    tious from 2 weeks before clinical symptoms until a few
                   There is a 50% mortality in patients presenting for the  days after the onset of jaundice. The mechanism of hep-
                   first time with bleeding oesophageal varices. Prognosis  atocyte necrosis is unclear; the virus is not cytopathic in
                   is worse in patients with high Child–Pugh grading (see  tissue culture.
                   page 196). Without treatment to prevent recurrence two
                   thirds of patients re-bleed whilst in hospital and 90%  Clinical features
                   re-bleed within a year.                      Exposure and infection in early childhood is usually
                                                                asymptomatic.Symptomsandseverityincreasewithage.
                                                                A history of contact/travel abroad may be found, al-
                   Viral hepatitis                              thoughmanyasymptomaticcasesoccur.Patientspresent
                                                                with a prodromal phase (malaise, anorexia, nausea, aver-
                   Definition                                    sion to fatty foods and cigarettes) lasting about a week.
                   The term viral hepatitis usually refers specifically to the  Jaundice appears after the prodromal phase and lasts
                   diseases of the liver caused by the hepatotropic viruses,  about 2 weeks. The liver may be palpably enlarged and
                   which include hepatitis A, B, C, D, E (see Table 5.5).  tender.
                   Other viruses such as the Epstein–Barr virus and cy-
                                                                Complications
                   tomegalovirus may cause acute hepatitis.
                                                                Intrahepatic cholestasis resulting in dark urine and pale
                                                                stools. Rarely, aplastic anaemia in children, which has
                   Pathophysiology                              a high mortality. Very occasionally fulminant hepatic
                   The hepatotrophic viruses can cause a range of  failure occurs.
                   pathologically and clinically evident liver disease (see
                   Fig. 5.6).                                   Investigations
                                                                Diagnosed by the finding of HAV-specific IgM. IgG
                                                                anti-HAV appears as IgM, disappears over the follow-
                   Hepatitis A                                  ing months and persists for years, giving immunity.
                   Definition                                    Management
                   Hepatitis A virus (HAV) is one of the hepatotrophic  Treatment is supportive. Prevention by HAV vaccina-
                   viruses, which cause viral hepatitis.        tion, a killed whole virus vaccine.
   199   200   201   202   203   204   205   206   207   208   209